Cargando…
Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug–Bug Interaction?
Gut microbial metabolism is not only an important source of uremic toxins but may also help to maintain the vitamin K stores of the host. We hypothesized that sevelamer therapy, a commonly used phosphate binder in patients with end-stage kidney disease (ESKD), associates with a disturbed gut microbi...
Autores principales: | Dai, Lu, Meijers, Björn K., Bammens, Bert, de Loor, Henriette, Schurgers, Leon J., Qureshi, Abdul Rashid, Stenvinkel, Peter, Evenepoel, Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354623/ https://www.ncbi.nlm.nih.gov/pubmed/32471179 http://dx.doi.org/10.3390/toxins12060351 |
Ejemplares similares
-
Uremic Toxins and Vascular Calcification–Missing the Forest for All the Trees
por: Rapp, Nikolas, et al.
Publicado: (2020) -
Lipid Profile Is Negatively Associated with Uremic Toxins in Patients with Kidney Failure—A Tri-National Cohort
por: Hobson, Sam, et al.
Publicado: (2022) -
Food-Derived Uremic Toxins in Chronic Kidney Disease
por: Lauriola, Mara, et al.
Publicado: (2023) -
Effects of an SGLT Inhibitor on the Production, Toxicity, and Elimination of Gut-Derived Uremic Toxins: A Call for Additional Evidence
por: Evenepoel, Pieter, et al.
Publicado: (2022) -
Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients
por: Paats, Joosep, et al.
Publicado: (2020)